Racial variability in immune responses only partially explains differential systemic sclerosis disease severity

By sjmartinez • July 18, 2024

Kuchinad KE, Kim JS, Woods A, Leatherman G, Gutierrez-Alamillo L, Mayes MD, Domsic R, Ramos PS, Silver RM, Varga J, Saketkoo LA, Kafaja S, Shanmugan VK, Gordon J, Chung L, Bernstein EJ, Gourh P, Boin F, Kastner DL, Zeger SL, Casciola-Rosen L, Wigley FM, Shah AA. Racial variability in immune responses only partially explains differential systemic sclerosis disease severity. Ann Rheum Dis. 2024 Jul 17:ard-2023-225458. doi: 10.1136/ard-2023-225458. Epub ahead of print. PMID: 39019570.

Tags: autoantibodies, Cedars Sinai DoM, Epidemiology, Publications, Rheumatology, Risk factors, systemic sclerosis

Design and Rationale of the WARRIOR Ancillary Study for Coronary CT Angiographic Analysis

Tamarappoo B, Wolny R, Tomasino GF, Berman D, Handberg E, Pepine CJ, Lo MC, Budoff M, Shaw L, Shufelt C, Wei J, Gulati M, Merz[...]

Public Health

Tan ZS, Qureshi N, Sicotte N, Escovedo C, Hirsch A, Afrashteh A, Miles PB, Roberts P. Public Health. Alzheimers Dement. 2025 Dec;21 Suppl 6(Suppl 6):e101651.[...]

CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions

Patil T, Lin JJ, Cheema PK, Carrizosa DR, Burkard ME, Elamin YY, Desai J, Patel JD, Nagasaka M, Reckamp KL, Waqar SN, Bauman JR, Schram[...]